P Brunamonti Binello

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Bevacizumab is a humanized recombinant monoclonal antibody that blocks vascular endothelial growth factor (VEGF). Recently, its use has been related with osteneocrosis of the jaws (ONJ), a disease showing a histological pattern similar to bisphosphonate-related ONJ. The aim of this study is to describe an ONJ case-report following bevacizumab chemotherapy(More)
  • 1